We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

108 hedge funds and large institutions have $123M invested in VanEck Biotech ETF in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 6

65% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 20

7% more funds holding

Funds holding: 101 → 108 (+7)

1.2% less ownership

Funds ownership: 26.85% → 25.65% (-1.2%)

7% less capital invested

Capital invested by funds: $131M → $123M (-$8.66M)

17% less call options, than puts

Call options by funds: $1.16M | Put options by funds: $1.39M

Holders
108
Holders Change
+7
Holders Change %
+6.93%
% of All Funds
1.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
33
Reduced
20
Closed
6
Calls
$1.16M
Puts
$1.39M
Net Calls
-$234K
Net Calls Change
-$721K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$3.2M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.65M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.04M
4
KAS
Kestra Advisory Services
Texas
+$886K
5
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
+$576K

Top Sellers

Rank Fund Capital Flow
1
PAG
Pinnacle Advisory Group
Maryland
-$20.2M
2
HighTower Advisors
HighTower Advisors
Illinois
-$2.21M
3
FTUS
Flow Traders U.S.
New York
-$946K
4
LPL Financial
LPL Financial
California
-$407K
5
UBS Group
UBS Group
Switzerland
-$231K
Name Holding Trade Value Shares
Change 		Change in
Stake
CT
76
Caldwell Trust
Florida
$72.1K – – –
NSIM
77
North Star Investment Management
Illinois
$70K – – –
First Manhattan
78
First Manhattan
New York
$67K – – –
EIP
79
Ellis Investment Partners
Pennsylvania
$60K -$1.32K -8 -2%
KPCM
80
Kings Point Capital Management
New York
$46K – – –
TC
81
Truvestments Capital
Florida
$46K +$45.3K +275 New
AF
82
Arrow Financial
New York
$42K – – –
AFG
83
Albion Financial Group
Utah
$30K +$28.8K +175 New
AIM
84
Anchor Investment Management
South Carolina
$26.3K – – –
HNB
85
Huntington National Bank
Ohio
$26K – – –
US Bancorp
86
US Bancorp
Minnesota
$25K – – –
Carson Wealth (CWM LLC)
87
Carson Wealth (CWM LLC)
Nebraska
$24K – – –
WEC
88
Winslow Evans & Crocker
Massachusetts
$21K +$20.6K +125 New
APWM
89
Atlas Private Wealth Management
New York
$20K – – –
Fidelity Investments
90
Fidelity Investments
Massachusetts
$18K +$3.79K +23 +26%
M
91
MOTCO
Texas
$17K – – –
WT
92
Whittier Trust
California
$17K – – –
FWM
93
FSA Wealth Management
Massachusetts
$17K +$16.6K +101 New
APA
94
American Portfolios Advisors
New York
$17K -$4.12K -25 -20%
FP
95
Financial Perspectives
Minnesota
$14.9K – – –
CAPTRUST Financial Advisors
96
CAPTRUST Financial Advisors
North Carolina
$13K – – –
NFG
97
Next Financial Group
Texas
$13K – – –
CFA
98
Carroll Financial Associates
North Carolina
$12K – – –
ADL
99
Asset Dedication LLC
California
$10K – – –
RCA
100
Rowland Carmichael Advisors
Arizona
$10K +$9.88K +60 New
1 2 3
4
5

BBH Hedge Fund Activity: Q4 2020 in Review

108 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2020, worth a combined $123M — down 6.6% from $131M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BBH positions and 6 closed out — a net gain of 11 holders — while 33 added to existing stakes and 20 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $3.2M. The largest seller was Pinnacle Advisory Group, exiting entirely with an estimated $20.2M sold.

  • 108 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2020, up from 101 in Q3 2020.
  • Funds reported $123M of VanEck Biotech ETF stock for Q4 2020, down 6.6% quarter-over-quarter.
  • 17 funds opened new VanEck Biotech ETF positions in Q4 2020 and 6 closed out, a net change of +11 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2020 was Goldman Sachs, an estimated $3.2M added.
  • The largest VanEck Biotech ETF seller in Q4 2020 was Pinnacle Advisory Group, an estimated $20.2M sold.

Based on aggregated 13F filings for Q4 2020.